Ankit Kansagra, MD, discusses key updates with CAR T-cell therapy in hematologic cancers.
Ankit Kansagra, MD
Advertisement
Articles by Ankit Kansagra, MD
Ankit Kansagra, MD, discusses updates with CAR T-cell therapy in multiple myeloma.
Ankit Kansagra, MD, discusses remaining questions with CAR T-cell therapy in multiple myeloma.
Ankit Kansagra, MD, discusses the expanding role of CAR T-cell therapy in lymphoma and multiple myeloma.
Advertisement
Latest Updated Articles
Dr. Kansagra on Expanding Role of CAR T-Cell Therapy in Lymphoma and Multiple MyelomaPublished: February 4th 2020 | Updated:
Dr. Kansagra on Remaining Questions With CAR T-Cell Therapy in Multiple MyelomaPublished: February 13th 2020 | Updated:
Dr. Kansagra on Updates With CAR T-cell Therapy in MyelomaPublished: April 18th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
Third NDA for Rivoceranib/Camrelizumab Is Resubmitted to FDA for Unresectable HCC
3
Northwestern Medicine Surgeons Develop a Total Artificial Lung System to Keep a Patient Alive for 48 Hours After Removing Both Lungs, Enabling a Double-Lung Transplant
4
Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD
5